XML 35 R24.htm IDEA: XBRL DOCUMENT v3.21.1
Formation and Business of the Company - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended
Jun. 01, 2016
Jul. 31, 2016
Mar. 31, 2021
Apr. 30, 2021
Dec. 31, 2019
Grant [Line Items]          
Revenue from product development award     $ 256,000    
Cancer Prevention & Research Institute of Texas [Member]          
Grant [Line Items]          
Expected milestone payments       $ 6,000,000  
Revenue from product development award   $ 20,000,000      
Grant termination date Nov. 30, 2019        
Percentage of cash required to raise in matching funds 50.00%        
Cash required to raise in matching funds $ 10,000,000        
Term of project during which cash required to raise in matching funds 3 years        
Cash required in matching funds raised $ 10,000,000        
Percentage of grant award proceeds required to pay 400.00%        
Cancer Prevention & Research Institute of Texas [Member] | Maximum [Member]          
Grant [Line Items]          
Percentage of grant award proceeds required to pay thereafter until government exclusivity maintained 1.00%        
Stanford University [Member] | Maximum [Member]          
Grant [Line Items]          
Milestone payments upon achievement of clinical and regulatory milestones         $ 1,000,000